Clinical trial · Interventional
Negative Pressure Wound Therapy in Groin Dissection
A Randomised Controlled Trial Comparing PICO™ Single Use Negative Pressure Wound Therapy System (Smith & Nephew Healthcare Limited, UK) to Conventional Wound Care Following Inguinal Lymphadenectomy for Metastatic Cutaneous Malignancy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study investigates the use of a negative pressure wound therapy device (PICO™, Smith \& Nephew Healthcare, UK) on clean, closed surgical wounds, in patients who are undergoing inguinal lymphadenectomy for metastatic carcinoma of cutaneous origin.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasm Metastasis | — | UNRESOLVED | — |
| Non-healing Surgical Wound (Disorder) | — | UNRESOLVED | — |
| Secondary Malignant Neoplasm of Lymph Node | — | UNRESOLVED | — |
| Skin Neoplasms | Skin Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PICO™ | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- PICO™
- description
- Use of PICO™ system negative pressure wound therapy device on surgical wound for up to seven days.
- interventionNames
- Device: PICO™
- type
- NO_INTERVENTION
- label
- Conventional wound care
- description
- Usual wound dressings will be used as comparison group.
Primary outcomes (1)
- measure
- Time to wound healing
- timeFrame
- From date of surgery until epithelial integrity is restored at the surgical site. Assessed at least weekly until wound is healed, up to 20 weeks after surgery
- description
- Determination of wound healing
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically- or cytologically-proven inguinal lymph node metastases from neoplasm of cutaneous origin Exclusion Criteria: * inability to give informed consent for participation
References
Publications (0)
Data not yet available